CCR4 and prostate carcinoma: CCR4 is preferentially expressed on TI-Treg cells rather than on Teff cells [25], with the CCL17/22-CCR4 axis playing an important role in lymphomas and in breast, lung, ovarian, gastric, and prostate cancers [23, 95, 96].